Literature DB >> 8654071

Occupational allergic contact dermatitis in construction workers.

L Condé-Salazar1, D Guimaraens, C Villegas, A Romero, M A Gonzalez.   

Abstract

We report the patch test results of 449 construction workers who came as patients to the Occupational Dermatology Service of the Instituto Nacional de Medicina y Seguridad del Trabajo in Madrid between 1989 and 1993. 90.8% of them were patch tested, because they had cutaneous lesions or a clinical history suggestive of occupational dermatitis. 65.5% (268) of those patch tested showed one or more reactions connected with their work. Chromate at 42.1% was the main allergen, followed by cobalt, 20.5%, nickel, 10%, and epoxy resin, 7.5%. 25.9% (106) of patients showed sensitization to rubber components, the majority at 23.7% to thiuram mix, with TETD being the main allergen.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8654071     DOI: 10.1111/j.1600-0536.1995.tb00471.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  3 in total

1.  Occupational contact allergy in the building trade in Germany: influence of preventive measures and changing exposure.

Authors:  Johannes Geier; Andrea Krautheim; Wolfgang Uter; Holger Lessmann; Axel Schnuch
Journal:  Int Arch Occup Environ Health       Date:  2010-09-24       Impact factor: 3.015

Review 2.  What Is New in Occupational Allergic Contact Dermatitis in the Year of the COVID Pandemic?

Authors:  Erica B Lee; Marissa Lobl; Aubree Ford; Vincent DeLeo; Brandon L Adler; Ashley Wysong
Journal:  Curr Allergy Asthma Rep       Date:  2021-03-29       Impact factor: 4.806

3.  Topical inflammasome inhibition with disulfiram prevents irritant contact dermatitis.

Authors:  Hanna Bonnekoh; Carolina Vera; Angela Abad-Perez; Silke Radetzki; Martin Neuenschwander; Edgar Specker; Niklas Amadeus Mahnke; Stefan Frischbutter; Eicke Latz; Marc Nazaré; Jens V Kries; Marcus Maurer; Jörg Scheffel; Karoline Krause
Journal:  Clin Transl Allergy       Date:  2021-07-22       Impact factor: 5.871

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.